Breaking News Instant updates and real-time market news.

LKSD

LSC Communications

$0.00 /

+ (+0.00%)

08:24
09/15/20
09/15
08:24
09/15/20
08:24

LSC Communications announces sale to Atlas Holdings, supporting creditors

LSC Communications said in a release, "LSC Communications announced that the Company has entered into a stock and asset purchase agreement with an affiliate of Atlas Holdings LLC with the support of certain of LSC's secured creditors. Under the terms of the Purchase Agreement, Atlas Holdings will acquire substantially all of the Company's assets through a combination of cash and a credit bid of obligations under the Company's secured term loan facility and senior secured notes at the direction of the Creditor Group. The Purchaser will also assume certain liabilities of the Company, including, subject to certain prerequisite conditions being satisfied, obligations related to the Company's qualified pension plan. Under the Purchase Agreement, the Purchaser will receive certain deal protections as previously authorized by the U.S. Bankruptcy Court for the Southern District of New York. The transaction is subject to Court approval and to other customary closing conditions, including regulatory approvals. The transaction is expected to close during the fourth quarter of 2020."

TODAY'S FREE FLY STORIES

Hot Stocks
J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use  07:15
04/13/21
04/13
07:15
04/13/21
07:15
JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

Hot Stocks
Extreme Networks appoints John Abel as CIO » 07:14
04/13/21
04/13
07:14
04/13/21
07:14
EXTR

Extreme Networks

$9.47 /

+0.06 (+0.64%)

Extreme Networks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

02/24/21 Lake Street
Extreme Networks price target raised to $12 from $8 at Lake Street
02/10/21 B. Riley Securities
Extreme Networks price target raised to $12.50 from $11 at B. Riley Securities
01/28/21 Lake Street
Extreme Networks price target raised to $8 from $6 at Lake Street
01/28/21 B. Riley Securities
Extreme Networks price target raised to $11 from $9.50 at B. Riley Securities
EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

EXTR Extreme Networks
$9.47 /

+0.06 (+0.64%)

Hot Stocks
FDA, CDC confirm recommendation to pause use of J&J COVID-19 vaccine » 07:14
04/13/21
04/13
07:14
04/13/21
07:14
JNJ

Johnson & Johnson

$161.62 /

+0.42 (+0.26%)

In a series of tweets,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

JNJ Johnson & Johnson
$161.62 /

+0.42 (+0.26%)

Initiation
Lumos Pharma initiated with a Buy at JonesTrading » 07:13
04/13/21
04/13
07:13
04/13/21
07:13
LUMO

Lumos Pharma

$10.99 /

-0.32 (-2.83%)

JonesTrading analyst Lina…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

03/11/21 Stifel
Lumos Pharma upgraded to Buy from Hold at Stifel
12/03/20
Fly Intel: Top five analyst initiations
12/03/20 Cantor Fitzgerald
Lumos Pharma initiated with an Overweight at Cantor Fitzgerald
12/02/20 Cantor Fitzgerald
Lumos Pharma initiated with an Overweight at Cantor Fitzgerald
LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

LUMO Lumos Pharma
$10.99 /

-0.32 (-2.83%)

Hot Stocks
MEI Pharma completes enrollment in Phase 2 Tidal study » 07:12
04/13/21
04/13
07:12
04/13/21
07:12
MEIP

MEI Pharma

$3.39 /

-0.04 (-1.17%)

MEI Pharma and Kyowa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
05/29/20
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

MEIP MEI Pharma
$3.39 /

-0.04 (-1.17%)

Recommendations
Nvidia price target raised to $700 from $620 at Credit Suisse » 07:12
04/13/21
04/13
07:12
04/13/21
07:12
NVDA

Nvidia

$608.46 /

+33.14 (+5.76%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

07:08 Today Deutsche Bank
Nvidia price target raised to $575 from $560 at Deutsche Bank
06:57 Today Mizuho
Nvidia price target raised to $675 from $650 at Mizuho
06:56 Today Susquehanna
Nvidia to invest heavily into data center space, says Susquehanna
06:09 Today Barclays
Nvidia price target raised to $650 from $600 at Barclays
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

Upgrade
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility » 07:11
04/13/21
04/13
07:11
04/13/21
07:11
BMY

Bristol-Myers

$62.70 /

+0.09 (+0.14%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

06:08 Today Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
02/12/21 Morgan Stanley
Amgen court decision may have readthrough for Gilead, says Morgan Stanley
BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

BMY Bristol-Myers
$62.70 /

+0.09 (+0.14%)

Recommendations
TripAdvisor price target raised to $29 from $24 at Jefferies » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
TRIP

TripAdvisor

$51.17 /

-1.27 (-2.42%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

04/05/21 Evercore ISI
TripAdvisor assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
TripAdvisor initiated with a Peer Perform at Wolfe Research
03/12/21 Truist
TripAdvisor price target raised to $62 from $48 at Truist
03/02/21 Citi
TripAdvisor upgraded to Buy from Neutral at Citi
TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

TRIP TripAdvisor
$51.17 /

-1.27 (-2.42%)

Hot Stocks
Bausch Health eye health business announces GOBI trial meets all endpoints » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
BHC

Bausch Health

$29.93 /

-0.86 (-2.79%)

Bausch + Lomb, a global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

03/24/21
Fly Intel: Top five analyst downgrades
03/24/21 BofA
BofA downgrades Bausch Health to Underperform, sees stock 'priced to perfection'
03/24/21 BofA
Bausch Health downgraded to Underperform from Neutral at BofA
03/16/21 H.C. Wainwright
Bausch Health price target raised to $55 from $50 at H.C. Wainwright
BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

BHC Bausch Health
$29.93 /

-0.86 (-2.79%)

Recommendations
Expedia price target raised to $175 from $145 at Jefferies » 07:10
04/13/21
04/13
07:10
04/13/21
07:10
EXPE

Expedia

$171.77 /

-3.14 (-1.80%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

EXPE Expedia
$171.77 /

-3.14 (-1.80%)

04/05/21 Evercore ISI
Expedia assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
Expedia initiated with a Peer Perform at Wolfe Research
03/30/21 Gordon Haskett
Expedia initiated with a Buy at Gordon Haskett
03/25/21 Morgan Stanley
Expedia price target raised to $200 from $160 at Morgan Stanley
EXPE Expedia
$171.77 /

-3.14 (-1.80%)

EXPE Expedia
$171.77 /

-3.14 (-1.80%)

EXPE Expedia
$171.77 /

-3.14 (-1.80%)

EXPE Expedia
$171.77 /

-3.14 (-1.80%)

Recommendations
Nasdaq price target raised to $164 from $160 at Deutsche Bank » 07:09
04/13/21
04/13
07:09
04/13/21
07:09
NDAQ

Nasdaq

$156.17 /

+0.15 (+0.10%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

04/09/21 UBS
Nasdaq price target raised to $178 from $170 at UBS
04/08/21 Piper Sandler
Nasdaq price target raised to $165 from $160 at Piper Sandler
01/29/21 Citi
Nasdaq price target raised to $147 from $144 at Citi
01/28/21 Barclays
Nasdaq price target raised to $160 from $155 at Barclays
NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

NDAQ Nasdaq
$156.17 /

+0.15 (+0.10%)

Upgrade
Booking Holdings upgraded to Buy on coming travel rebound at Jefferies » 07:09
04/13/21
04/13
07:09
04/13/21
07:09
BKNG

Booking Holdings

$2,409.04 /

-30.64 (-1.26%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

06:48 Today Jefferies
Booking Holdings upgraded to Buy from Hold at Jefferies
04/05/21 Evercore ISI
Booking Holdings assumed with an In Line at Evercore ISI
03/31/21 Wolfe Research
Booking Holdings initiated with an Outperform at Wolfe Research
03/30/21 Gordon Haskett
Booking Holdings initiated with a Hold at Gordon Haskett
BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

BKNG Booking Holdings
$2,409.04 /

-30.64 (-1.26%)

Downgrade
Idacorp downgraded to Neutral from Buy at BofA » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
IDA

Idacorp

$100.06 /

+0.49 (+0.49%)

BofA analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDA Idacorp
$100.06 /

+0.49 (+0.49%)

01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
01/06/21 Wells Fargo
Idacorp downgraded to Underweight from Equal Weight at Wells Fargo
05/04/20 Sidoti
Idacorp upgraded to Buy on valuation at Sidoti
05/04/20 Sidoti
Idacorp upgraded to Buy from Neutral at Sidoti
IDA Idacorp
$100.06 /

+0.49 (+0.49%)

Hot Stocks
Evogene's Biomica demonstrates efficacy of BMC128 in studies » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
EVGN

Evogene

$4.37 /

-0.26 (-5.62%)

Biomica, a subsidiary of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVGN Evogene
$4.37 /

-0.26 (-5.62%)

EVGN Evogene
$4.37 /

-0.26 (-5.62%)

11/30/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight
11/30/20 Cantor Fitzgerald
Evogene initiated with an Overweight at Cantor Fitzgerald
EVGN Evogene
$4.37 /

-0.26 (-5.62%)

Recommendations
Nvidia price target raised to $575 from $560 at Deutsche Bank » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
NVDA

Nvidia

$608.46 /

+33.14 (+5.76%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

06:57 Today Mizuho
Nvidia price target raised to $675 from $650 at Mizuho
06:56 Today Susquehanna
Nvidia to invest heavily into data center space, says Susquehanna
06:09 Today Barclays
Nvidia price target raised to $650 from $600 at Barclays
04/12/21 Lynx
Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

Syndicate
Liquidia Technologies announces $21.7M private placement » 07:08
04/13/21
04/13
07:08
04/13/21
07:08
LQDA

Liquidia Technologies

$2.53 /

-0.05 (-1.94%)

Liquidia Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

12/04/20
Fly Intel: Top five analyst initiations
12/04/20 H.C. Wainwright
Liquidia Technologies initiated with a Buy at H.C. Wainwright
11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 Wedbush
Liquidia Technologies downgraded to Neutral from Outperform at Wedbush
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

  • 30
    Jun
LQDA Liquidia Technologies
$2.53 /

-0.05 (-1.94%)

Hot Stocks
Rigel announces results from Phase 2 clinical trial of fostamatinib » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
RIGL

Rigel Pharmaceuticals

$3.10 /

-0.155 (-4.77%)

Rigel Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
11/09/20
Fly Intel: Top five analyst downgrades
11/09/20 JPMorgan
Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

RIGL Rigel Pharmaceuticals
$3.10 /

-0.155 (-4.77%)

Hot Stocks
Castle Biosciences says DecisionDx-Melanoma is significant predictor of outcomes » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
CSTL

Castle Biosciences

$67.54 /

-1.9 (-2.74%)

Castle Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

03/09/21 Baird
Castle Biosciences price target lowered to $82 from $87 at Baird
02/03/21 KeyBanc
Castle Biosciences price target raised to $90 from $70 at KeyBanc
01/26/21 Canaccord
Castle Biosciences price target raised to $84 from $80 at Canaccord
01/15/21 SVB Leerink
Castle Biosciences price target raised to $80 from $70 at SVB Leerink
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

  • 16
    Dec
  • 25
    Jun
CSTL Castle Biosciences
$67.54 /

-1.9 (-2.74%)

Initiation
Truist starts Instil Bio with a Buy citing efficacy in solid tumors » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
TIL

Instil Bio

$22.13 /

+0.05 (+0.23%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

06:18 Today Truist
Instil Bio initiated with a Buy at Truist
06:00 Today Cowen
Instil Bio initiated with an Outperform at Cowen
05:59 Today Morgan Stanley
Instil Bio initiated with an Equal Weight at Morgan Stanley
  • 19
    Mar
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

Hot Stocks
Versus Systems' adds functionality to prizing engine to support uses in India » 07:07
04/13/21
04/13
07:07
04/13/21
07:07
VRSSF

Versus Systems

/

+

Versus Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    HCA Healthcare price target raised to $210 from $180 at Deutsche Bank » 07:07
    04/13/21
    04/13
    07:07
    04/13/21
    07:07
    HCA

    HCA Healthcare

    $191.65 /

    +0.54 (+0.28%)

    Deutsche Bank analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    04/09/21 Mizuho
    HCA Healthcare price target raised to $205 from $195 at Mizuho
    02/05/21 Mizuho
    HCA Healthcare price target raised to $195 from $180 at Mizuho
    02/04/21
    HCA Healthcare price target raised to $203 from $164 at UBS
    02/03/21 Citi
    HCA Healthcare price target raised to $191 from $185 at Citi
    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    HCA HCA Healthcare
    $191.65 /

    +0.54 (+0.28%)

    Syndicate
    Bally's announces commencement of stock, tangible equity unit offerings » 07:07
    04/13/21
    04/13
    07:07
    04/13/21
    07:07
    BALY

    Bally's

    $60.79 /

    -0.885 (-1.43%)

    , JKPTF

    Gamesys Group

    $27.00 /

    + (+0.00%)

    Bally's Corporation…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    JKPTF Gamesys Group
    $27.00 /

    + (+0.00%)

    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    04/08/21 KeyBanc
    Bally's price target raised to $70 from $65 at KeyBanc
    03/29/21 Truist
    Early March casino data looks 'very positive,' says Truist
    03/25/21 Stifel
    Bally's price target raised to $75 from $70 at Stifel
    03/24/21 Jefferies
    Gamesys Group and Bally's an 'interesting combination,' says Jefferies
    JKPTF Gamesys Group
    $27.00 /

    + (+0.00%)

    03/24/21 Jefferies
    Gamesys Group and Bally's an 'interesting combination,' says Jefferies
    03/16/21 Jefferies
    Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
    03/10/21 Berenberg
    Gamesys Group price target raised to 1,700 GBp from 1,550 GBp at Berenberg
    03/10/21 Deutsche Bank
    Gamesys Group price target raised to 1,580 GBp from 1,510 GBp at Deutsche Bank
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    JKPTF Gamesys Group
    $27.00 /

    + (+0.00%)

    Recommendations
    ArcelorMittal price target raised to $36 from $30 at Deutsche Bank » 07:06
    04/13/21
    04/13
    07:06
    04/13/21
    07:06
    MT

    ArcelorMittal

    $28.95 /

    -0.02 (-0.07%)

    Deutsche Bank analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    04/12/21 UBS
    ArcelorMittal price target raised to EUR 30 from EUR 25 at UBS
    04/09/21 Morgan Stanley
    ArcelorMittal price target raised to EUR 28.50 from EUR 28 at Morgan Stanley
    03/24/21 Morgan Stanley
    ArcelorMittal price target raised to EUR 28 from EUR 24 at Morgan Stanley
    02/22/21 Morgan Stanley
    ArcelorMittal price target raised to EUR 24 from EUR 23 at Morgan Stanley
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    • 12
      May
    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    MT ArcelorMittal
    $28.95 /

    -0.02 (-0.07%)

    Hot Stocks
    Bally's to acquire Tropicana Las Vegas from Gaming and Leisure Properties » 07:05
    04/13/21
    04/13
    07:05
    04/13/21
    07:05
    BALY

    Bally's

    $60.79 /

    -0.885 (-1.43%)

    , GLPI

    Gaming and Leisure Properties

    $43.37 /

    +0.11 (+0.25%)

    Bally's (BALY)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    GLPI Gaming and Leisure Properties
    $43.37 /

    +0.11 (+0.25%)

    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    04/08/21 KeyBanc
    Bally's price target raised to $70 from $65 at KeyBanc
    03/29/21 Truist
    Early March casino data looks 'very positive,' says Truist
    03/25/21 Stifel
    Bally's price target raised to $75 from $70 at Stifel
    03/24/21 Jefferies
    Gamesys Group and Bally's an 'interesting combination,' says Jefferies
    GLPI Gaming and Leisure Properties
    $43.37 /

    +0.11 (+0.25%)

    03/31/21 Mizuho
    Gaming and Leisure Properties initiated with a Buy at Mizuho
    03/15/21
    Fly Intel: Top five analyst initiations
    03/15/21 KeyBanc
    Gaming and Leisure Properties initiated with an Overweight at KeyBanc
    02/22/21 Deutsche Bank
    Gaming and Leisure Properties price target raised to $51 from $48 at Deutsche Bank
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    GLPI Gaming and Leisure Properties
    $43.37 /

    +0.11 (+0.25%)

    • 30
      Oct
    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    BALY Bally's
    $60.79 /

    -0.885 (-1.43%)

    Hot Stocks
    908 Devices appoints Michele Fournier as Chief People Officer » 07:04
    04/13/21
    04/13
    07:04
    04/13/21
    07:04
    MASS

    908 Devices

    $50.85 /

    +1.05 (+2.11%)

    908 Devices announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    01/12/21 SVB Leerink
    908 Devices initiated with an Outperform at SVB Leerink
    01/12/21 Cowen
    Cowen starts 908 Devices at Outperform, sees 'mass-ive opportunity'
    01/12/21 William Blair
    908 Devices initiated with an Outperform at William Blair
    01/12/21 SVB Leerink
    908 Devices initiated with an Outperform at SVB Leerink
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    • 18
      Dec
    MASS 908 Devices
    $50.85 /

    +1.05 (+2.11%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.